International Rett Syndrome Foundation Basic Research Grant Program
IRSF announces the availability of Regular Research grants for international biomedical research to promote the understanding of MeCP2 in the pathogenesis of the neurobehavioral phenotype of Rett syndrome (RTT). We seek to gain a better understanding of the underlying pathology of the disorder leading to an amelioration of the symptoms and a cure for RTT. IRSF seeks to encourage research that encompasses innovative therapeutic approaches and state of the art diagnostic techniques.
IRSF encourages applications within the following emphasis areas:
Understanding the role of MeCP2 during normal brain development
Characterizing the role of MeCP2, including MeCP2 target genes, in normal structure and function of the developing and adult nervous system
Determination of the relationship between patterns of expression of MeCP2, FoxG1, CDKL5, and related proteins in the nervous system and the neurologic and behavioral phenotypes of patients with RTT and/or related animal models
The investigation of neuronal abnormalities that result from MeCP2 dysfunction
The role of microglial and macroglial cells in development as it relates to RTT
Understanding mechanisms and systems leading to aberrant behavior in RTT
The development of assistive technologies to improve the quality of life of individuals affected by RTT
Support for other advances in therapy such as physical therapy, communication and education
The two year Regular Research Grants are designed to assist investigators establish hypotheses relevant to Rett syndrome research and obtain future funding from other agencies. The maximum funding level for research grants is $100,000 over two years.
Awards will be made in one cycle in 2013
Letters of Intent due: July 1, 2013
Invitation of full applications by: July 19, 2013
Applications due: August 19, 2013
Please Note: IRSF requires all applicants to use our online submission process.
For application submission inquiries, please contact:
Janice Ascano, Ph.D. Manager of Grants and Research - firstname.lastname@example.org | 917-267-4504
For program related inquiries, please contact:
Steve Kaminsky, Ph.D., Chief Science Officer - email@example.com | 301-961-1559